In a study of retinopathy during one year of tight blood glucose control 45 type I (insulin dependent) diabetics without proliferative retinopathy were randomised to receive either continuous subcutaneous insulin infusion, multiple insulin injections, or conventional insulin treatment (controls). Near 
Introduction
Retinopathy is one of the most common disabling complications of insulin dependent diabetes. Some 15-30% of young insulin dependent diabetics receiving conventional treatment lose vision later in life.1 A longitudinal study showed that patients who developed retinopathy had poorer diabetic control as estimated by glycosylated haemoglobin (HbA,c) values than patients who did not develop retinopathy.2 Hyperglycaemia is believed to be of major importance in the development of diabetic complications. 3 Near normoglycaemia can now be obtained in large patient populations with either multiple insulin injection treatment5 or continuous subcutaneous insulin infusion with insulin pumps. 6 7 Initial case reports described improvement of retinopathy during near normoglycaemia,8 but two controlled trials, the Steno9 and the Kroc study,'0 reported a slight deterioration of retinopathy. These studies were done in patients with established background retinopathy and long durations of diabetes. Possibly a "point of no return" had been passed at which progression of retinopathy could no longer be influenced by return of metabolite values to normal.9 Some uncontrolled studies reported similar results."1-3 We reported one patient with transient proliferative retinopathy during continuous subcutaneous insulin infusion. '4 We have designed a controlled, prospective trial in patients with shorter durations of diabetes and less background retinopathy than in other controlled studies and reported transient worsening of retinopathy after six months of continuous subcutaneous insulin infusion and multiple injections of insulin."5 This paper reports the results after one year, showing the association between rapid improvement of blood glucose control and worsening of retinopathy. It is also the first study to record transient worsening of retinopathy during multiple insulin injection treatment.
Patients and methods
The study protocol was approved by the ethical committee of the Norwegian Council for Science and the Humanities. Forty five C peptide negative insulin dependent diabetics aged 18-42 years with a history of the disease for more than seven years were included in the study after giving written, informed consent. During two months before the study ("preperiod") home blood glucose monitoring was introduced and baseline results obtained. All patients used two daily insulin injections. They were then randomly assigned to three different modes of treatment: either continuous subcutaneous insulin infusion, multiple insulin injections, or continued conventional treatment with two daily injections of mixed insulin (controls). Block randomisation was performed to ensure comparable groups (table I) .
In the control group a mixture of rapid and isophane insulin was injected before breakfast and dinner. In the multiple injection group rapid acting insulin was injected before each meal (four to six times daily) and isophane insulin given at bedtime. Patients were free to inject the dose at mealtimes either through a subcutaneous butterfly needle taped to the abdomen or by conventional injections. Two different pumps were used for continuous subcutaneous infusion. Three patients used a Nordisk Infuser (Nordisk Gentofte, Denmark) and 12 the AutoSyringe AS6C (Travenol, USA). Only highly purified porcine insulin preparations were used (Nordisk, Novo). Continuous subcutaneous infusion and multiple injection treatment were started and optimised during five days in the diabetes unit. The patients were followed up by two of us in the outpatient clinic after one and three weeks and monthly thereafter.
HbA, was determined monthly by agar gel electrophoresis (Glytrac, Corning) after elimination of the labile fraction (normal range (2SD) 5 4-7 6'; coefficient of variation < 50" ). 16 HbA,, was determined by ion exchange chromatography (normal range (2SD) 4 2-6 00'; coefficient of variation < 3zo ). 16 mg/100 ml) to 1-2 (0 4) mmol/l (22 (7) mg/ 100 ml); multiple injection group: from 1 9 (0-3) mmol/l (34 (5) mg/100 ml) to 0 5 (0 4) mmol/I (9 (7) mg/100 ml); controls: from 1-9 (0 3) mmol/1 (34 (5) mg/100 ml) to 2-0 (0 4) mmol/1 (36 (7) mg/100 ml)-multiple injection group v controls p < 0 05). The variation from day to day was reduced similarly. The proportion of HbAl was substantially reduced in the preperiod in all groups (fig 1) , reflecting higher blood glucose concentrations before the study. After allocation a further reduction in HbA, was observed in the continuous infusion and multiple injection groups (p < 0 001). HbA, in the control group was unchanged after allocation and remained higher than in the other two groups for one year (p < 0 01).
By "blind" evaluation of the fluorescein angiograms a slight continuous progression of retinopathy was observed in the control group (p <001). In the group given continuous subcutaneous infusion a significant deterioration was observed during the first three months of treatment (p < 001). This deterioration was transient, however, Irpeiod the retinopathy improving from the sixth month (p <0 05). In the multiple injection group no significant changes were detected by this method (table II) . One patient developed transient proliferative retinopathy in both eyes after three months of continuous infusion. Treatment was continued, however,14 and within three months all retinal changes had regressed without laser treatment.
By indirect ophthalmoscopy and binocular split lamp biomicroscopy 15 patients were identified who developed cotton wool spots after three to six months of treatment: seven were among the 15 patients treated by continuous infusion and eight among the 15 treated by multiple injections. No patient in the control group developed cotton wool spots (table III) . This observation was confirmed by blind evaluation of colour photographs of the fundi, which identified new cotton wool spots in eight patients treated by continuous infusion or multiple injections but in none of the controls. Cotton wool spots were typically concentrated in the optic disc area, 1-20 spots (mean 4 6) being found values below 2-5 mmol/l (45 mg/100 ml) two to four months after initiation of continuous infusion or multiple injections than had patients who did not develop these spots (14 (SEM 2)oo v 8 (2)%; p<0 05) (table IV). Episodes of mild symptomatic hypoglycaemia occurred with a frequency of one or two a week in the preperiod, and this did not change significantly after allocation. No significant difference in the frequency of symptomatic hypoglycaemia was observed among treatment groups. Patients who developed cotton wool spots increased the frequency by one a week but the others did not (NS).
The incidence of cotton wool spots was higher among women than men (p < 0 05) (table V). The incidence was also higher in patients who already had microaneurysms when treatment began (p < 0-05) and in those whose diabetes was of more than 10 years' duration (p < 0 01).
When reduction of HbAl in patients who developed cotton wool spots was corrected for sex, duration of diabetes, and severity of initial retinopathy the difference remained. 
Discussion
This study shows that returning the blood glucose concentration to near normal by continuous subcutaneous insulin infusion or multiple injections of insulin in insulin dependent diabetics with previous average or poor blood glucose control may promote deterioration of retinopathy. The most striking change is the development of cotton wool spots in these patients.
Cotton wool spots in the retina seem to represent microinfarctions in the nerve fibre layer, associated with focal ischaemia.'0 '9 Impaired retinal perfusion together with reduced nutrient substrate concentrations during improved blood glucose control may be one plausible hypothesis for this event.20
The development of cotton wool spots in our series was clearly related to mode of treatment; no patient receiving two daily injections of rapid or intermediate acting insulin developed cotton wool spots compared with half of the patients treated with continuous subcutaneous infusion and multiple injections. When intensive treatment began the groups were closely comparable in factors known to be relevant in the development of retinopathy-namely, age, duration of diabetes, and degree of diabetic control. The groups were also comparable in the severity of retinopathy at that time.
Cotton wool spots developed predominantly during the first months of treatment and regressed in most patients over three to nine months. The reported half time of cotton wool spots in diabetes is 8-17 months,2' so the spots observed in our series may have been less damaging to the retina.
The main difference between conventional and intensive modes of treatment is in the resulting blood glucose concentrations. In this study the mean blood glucose concentration was lower in the continuous infusion and multiple injection groups. It may also be important, however, that the difference between preprandial and postprandial values was significantly reduced during intensive treatment.
All groups improved their blood glucose control as compared with before the study. The decrement in blood glucose was similar in patients who did not develop cotton wool spots and controls. Patients who did develop cotton wool spots, however, had a much larger fall in mean blood glucose and HbA, values. This suggests that a large fall in the blood glucose concentration may be deleterious for the retina. This large fall in the blood glucose concentration began almost immediately after the start of intensive treatment. Whether the speed or magnitude of blood glucose lowering is the most important factor remains unknown.
Light sensitive ganglion cell function is sensitive to hypoglycaemia. Colour perception reportedly diminishes during prolonged hypoglycaemia. We found no differences in the absolute frequency of subjective hypoglycaemia among treatment groups. This may have been because awareness of hypoglycaemia diminished in many patients in the continuous infusion and multiple injection groups. The frequency of objective hypoglycaemia, defined as a blood glucose concentration below 2 5 mmol/l (45 mg/100 ml), was higher in patients with cotton wool spots in the critical period two to four months after initiating continuous subcutaneous infusion and multiple injections. This suggests that increased hypoglycaemia may be responsible for the development of these spots. We have observed a transient deterioration of retinopathy associated with a rapid and large fall in the blood glucose concentration when initiating treatment with continuous subcutaneous insulin infusion or multiple injections. We do not know whether this will occur if the blood glucose concentration is reduced at a slower rate. So far we have examined the effect of lowering the blood glucose concentration over several months, and after the initial deterioration retinopathy seems to improve. The study is continuing to see if this improvement rcmains.
Introduction
The overall prognosis for the remission of epilepsy appears good, up to 70C> of patients in a community based study achieving long term remission of their epilepsy,' compared with the more pessimistic outlook for patients drawn from hospital based popuiations with chronic epilepsy, in whom roughly 300o achieve remission.2 The more optimistic outlook is supported by several studies of previously untreated patients, which suggest a high rate of success irrespective of which single anticonvulsant drug is used. - The success of monotherapy in these studies demands a serious appraisal of which single anticonvulsant drug should be prescribed first to the patient presenting with epilepsy,7a and the need for carefully controlled, long term comparisons of anticonvulsant drugs is plain. 8 We report the results of a randomised, controlled clinical trial comparing the efficacy of sodium valproate and phenytoin in newly diagnosed adult epileptic patients followed up for between two and four years.
